Active Ingredient History

BENOXAPROFEN is an anti-inflammatory drug indicated for the treatment of arthritis. It was marketed under the brand name ORAFLEX® in the US and as OPREN® in Europe by Eli Lilly and Company. In 1982 Eli Lilly voluntarily withdrew BENOXAPROFEN from the market due to postmarketing reports of severe liver toxicity in patients who took it.   NCATS

  • SMILES: CC(C(O)=O)C1=CC=C2OC(=NC2=C1)C3=CC=C(Cl)C=C3
  • Mol. Mass: 301.724
  • ALogP: 4.34
  • ChEMBL Molecule:
More Chemistry
(1)-2-(4-chlorophenyl)benzoxazole-5-propionic acid | 2-(2-(4-chlorophenyl)-1,3-benzoxazol-5-yl)propanoic acid | 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid | 2-(4-chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid | benoxaprofen | benoxaprofen ammonium | benoxaprofen, ammonium salt | benoxaprofene | benoxaprofen, (-)-isomer | benoxaprofen, (+-)-isomer | benoxaprofen, (+)-isomer | benoxaprofen monosodium | benoxaprofen, monosodium salt | benoxaprofeno | benoxaprofen sodium | benoxaprofenum | compound 90459 | dl-benoxaprofen | lrcl 3794 | oraflex


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue